teleo-codex/inbox/archive/2026-02-01-cms-2027-advance-notice-ma-rates.md
Teleo Agents f803c35db6 vida: directed research — MA, senior care, international comparisons
- 23 sources archived across 3 tracks
- Track 1: Medicare Advantage history & structure
- Track 2: Senior care infrastructure
- Track 3: International health system comparisons

Pentagon-Agent: Vida <HEADLESS>
2026-03-10 19:45:13 +00:00

3.4 KiB

type title author url date domain secondary_domains format status priority tags
source CMS 2027 Medicare Advantage and Part D Advance Notice: Chart Review Exclusion and Star Ratings Reform CMS / Multiple analysis sources https://www.cms.gov/newsroom/fact-sheets/2027-medicare-advantage-part-d-advance-notice 2026-02-01 health
report unprocessed high
cms
medicare-advantage
2027-rates
chart-review-exclusion
star-ratings
V28
risk-adjustment

Content

Chart Review Exclusion (2027)

  • CMS proposes excluding ALL diagnoses from unlinked chart review records (not tied to documented service)
  • Diagnoses from chart reviews allowed only if tied to actual medical encounter
  • Projected savings: >$7 billion in 2027
  • This is the most targeted reform to date against retrospective code-mining

V28 Phase-In Completion

  • 2026 is the FINAL year of V28 phase-in
  • 2027 model continues V28 clinical classification but recalibrated with newer data (2023 diagnoses, 2024 expenditures — updated from 2018/2019)
  • Notable: CKD Stage 3B and 3 now have separate coefficients (previously constrained to same value)

Star Ratings Reforms

  • New depression screening and follow-up measure (2027 measurement year, 2029 ratings)
  • CMS exploring modernization: AI-based risk adjustment, alternative data sources
  • Exploring timeline compression to reduce current 2-year lag between measurement and payment

Industry Impact

  • Insurers warn flat 2027 rates + chart review exclusion could drive benefit cuts and market exits
  • Combined with V28 completion, this is the most structurally significant reform year since MMA 2003
  • Purpose-built MA plans (lower coding intensity, genuine care delivery) are better positioned than acquisition-based plans

Forward-Looking Signals

  • CMS exploring next-generation AI-powered risk adjustment model
  • Potential for quality measurement timeline modernization
  • Signals continued regulatory tightening trajectory

Agent Notes

Why this matters: 2027 is shaping up as a structural inflection for MA. Chart review exclusion + V28 completion + flat rates = the first sustained compression of MA economics since the BBA 1997 crash. The key question: does this trigger another 1997-style plan exit cycle, or have purpose-built plans evolved enough to survive where acquisition-based models fail? What surprised me: CMS is exploring AI-powered risk adjustment. If implemented, this would fundamentally change the coding game — AI could detect upcoding patterns across millions of records in ways that audit sampling can't. KB connections: CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring, Devoted is the fastest-growing MA plan at 121 percent growth because purpose-built technology outperforms acquisition-based vertical integration during CMS tightening Extraction hints: Claim about 2027 as structural inflection year for MA economics — convergence of V28, chart review exclusion, and flat rates creating the first sustained compression since BBA 1997.

Curator Notes

PRIMARY CONNECTION: CMS 2027 chart review exclusion targets vertical integration profit arbitrage by removing upcoded diagnoses from MA risk scoring WHY ARCHIVED: Updates and deepens the existing KB claim with the full 2027 reform package context. EXTRACTION HINT: The parallel to BBA 1997 is the key analytical frame — will 2027 trigger plan exits or differentiation?